Skip to main content
Signal8
Marnix L. Bosch profile photo

Marnix L. Bosch

CIK: 0001253933

Recent activity

The filings on record name Marnix L. Bosch as Chief Technical Officer of Northwest Biotherapeutics Inc. (NWBO]).

The most recent transaction on file, dated Apr 3, 2023, was reported in a Form 4 filed Apr 5, 2023, 2 days after the transaction date.

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NORTHWEST BIOTHERAPEUTICS INC logo
NWBO]

NORTHWEST BIOTHERAPEUTICS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • NORTHWEST BIOTHERAPEUTICS INC logo
    NWBO]

    NORTHWEST BIOTHERAPEUTICS INC

    Apr 3, 2023
    Award(A)
    Direct
    119.4K shares at avg. $0.25$30K

1-1 of 1

Marnix L. Bosch files insider reports with the SEC as Chief Technical Officer of Northwest Biotherapeutics Inc. (NWBO]). Signal8 holds 1 reported Form 4/5 transaction by Marnix L. Bosch since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in NWBO], dated Apr 3, 2023.

About Marnix L. Bosch

Marnix L. Bosch (SEC CIK 0001253933) files insider reports with the SEC as Chief Technical Officer of NORTHWEST BIOTHERAPEUTICS INC (NWBO]).

Signal8 holds 1 ownership filing by Marnix L. Bosch, a Form 4, filed on Apr 5, 2023. Those filings report 1 transaction, the latest on Apr 3, 2023. Signal8's Form 4 history starts in Sep 2024.

The business address on Marnix L. Bosch's filings is in BETHESDA, MD.

Recent filings by Marnix L. Bosch

  • Apr 3, 2023: Grant or award of NWBO] shares (Form 4, code A).

How to read Form 4 transaction codes